INTRODUCTION
Obesity is a universal disease of epidemic propor tions and is increasing in prevalence. It is one of the main public health problems of modern society due to associated comorbidities affecting quality of life (QoL) in a significant manner.
The high prevalence of obesity has become as problematic as malnutrition. In the United States, 30.5% of the adult population is obese and 4.7% suffer from morbid obesity (6) , while in Canada, its prevalence in the population is 14.9% for obesity and 2.9% for morbid obesity (3) . In Brazil, according to data from the Geography and Statistics Brazilian Institute (IBGE), in the last 30 years the number of overweight men doubled (from 18.6% to 41%), and the number of obese men tripled (from 2.8% to 8.8%). Among women there was an increase of 50% in relation to being either overweight or obese (8) .
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OUTCOMES ON QUALITY OF LIFE, WEIGHT LOSS, AND COMORBIDITIES AFTER ROUX-EN-Y GASTRIC BYPASS
the second most common cause of death, after smoking, due to modifiable risk factors (6) . Presently, bariatric surgery is indicated for patients with a body mass index (BMI) greater than 40 or a BMI between 35 and 40 with comorbidities associated with obesity (16) . In line with this indication, the RouxenY gastric bypass (RYGBP) has been the most preferred form of bariatric surgery both in Brazil and elsewhere in the world (2, 7, 23) . There has been great interest in the outcomes of this procedure in relation to the evolution of weight loss, the resolution of comorbidities, and its impact on the QoL. In spite of extensive literature favoring bariatric procedures, several questions remain: Does the weight loss acquired through this surgery continue long term? What are the longterm impacts of associated comor bidities like diabetes, arterial hypertension, and arthropathy? Can the type of surgery used be individualized? Does the favorable QoL impression of these patients remain long term postoperative?
The aims of this study were to evaluate the longterm health outcomes as they relate to QoL, the evolution of weight loss, and the resolution of comorbidities over several RYGBP postoperative periods. The patients were divided into five groups, G1-G5, each one constituting 30, 26, 30, 27, and 30 patients, respectively. The groups were identified as follows: G1 included patients awaiting surgery (Control); G2 was 1 year post surgery (12 to 15 months); G3 was 2 years post (21 to 26 months); G4 was 3 years post (33 to 39 months); and G5 had 4 years or more of postsurgical followup. For the postoperative outcome evaluations we used the Bariatric Analysis and Reporting Outcome System (BAROS) (17) and the Medical Outcomes Study 36item Shortform Health Survey (SF36 TM ) (4, 26) questionnaires.
The BAROS questionnaire uses a standardized scoring system to evaluate various outcomes of bariatric surgery such as weight loss, comorbidities, and QoL. The number of points for each area are then summed and classified as failure, fair, good, very good, or excellent outcomes (17) . On the other hand, the SF36 TM survey is used to evaluate the QoL as a generic instrument focusing on the negative aspects (disease or illness) and the positive aspects (welfare) of health. The SF36 TM is a multiitem scale questionnaire that evaluates points of several clinical components such as functional capacity, physical activities, bodily pain, general state of health, vitality, social and emotional problems, and mental health, and compares these same components of the patients' current health with those obtained one year previous (4, 26) . The KruskalWallis test was applied for statistical analysis of the anthropometric data from the BAROS and the SF 36 TM questionnaires. When applicable, the BehrensFisher test for comparing one group to another group was used. For analysis of resolution among groups of comorbidities, the Test for Trends in Proportions was applied. A level of 0.05 was considered significant among groups. Table 1 presents the age, gender, and anthropometric data for the five groups. No significant difference was found between groups who underwent the RYGBP surgery related to preoperative BMI, current BMI, and percentage of excess body weight loss (EBWL%). The age and initial BMI were smaller in Group 1 than in the other groups.
RESULTS
The results for weight loss and the impact of comorbidi ties were similar between groups, while significant differences were found in the QoL between G2 and G3, showing a decline between the first and second years. However after 3, 4, or more years, the score for the postoperative QoL was similar to that of the control group (Table 2) .
Evaluation through use of the SF36 TM questionnaire revealed important improvements in QoL related to health (QLRH) in all domains of patients who underwent RYGBP in comparison to the control group. On the other hand, in dividualized evaluation of these aspects showed significant improvement in QoL for the first three years postsurgery. However, after four years (G5) the domains such as physi cal aspect, pain, vitality, social and emotional aspects, and mental health, were similar to those of the control group, except for general state of health and functional capacity, which remained better ( Figures 1A and 1B) . An evaluation of these postoperative groups revealed that the major prevalent comorbidities were arterial hypertension, diabetes mellitus, and arthropathy, and these aspects reached a resolution rate of 69.7%, 88.2% and 27.5%, respectively (Ta ble 3). When these comorbidities were evaluated separately by group, there was a statistically significant longterm decrease in the rate of the diabetes resolution (Table 4) .
Using qualitative outcomes obtained from the BAROS questionnaire, it was observed that an index of very good or excellent reached 90% or higher only in Group 2. When the number of outcomes was increased, the percentage of patients with good, very good, or excellent result was above 96% in all groups (Table 5) . 
DISCUSSION
Bariatric surgery has been the method most often used in obesity treatment for its effectiveness in weight loss, and for improvement of comorbidities and QoL. However it does not provide a definitive cure for obesity, and it requires per sistence in behavioral and lifestyle changes after surgery (2, 23) . In order to evaluate its outcomes, questionnaires have been used to collect data for comparison and for presentation effects. The lack of followup and the difficulty in obtain ing completed questionnaires are factors that interfere with the interpretation of outcomes for postoperative bariatric patients (5, 10, 12, 24) . In fact, Puzziferri et al., that obtained 75% of RYGBP patient followup for 3 years, reported that an address or city change was a key factor causing loss of followup for these patients (20) . In an attempt to avoid the inconvenience and difficulty of longterm followup, we randomly selected patients who were treated in the Hospital of the Servidor Público Estadual de São Paulo covering dif ferent postoperative periods.
Weight loss is the main parameter of the success or fail ure of bariatric surgery, and it has been used in all systems for postoperative clinical outcome evaluations including BAROS, which is the most wellknown questionnaire (17) . In the present study, the postoperative BMI ranged from 29.4 ± 5.6 to 31.6 ± 4.3 Kg/m² and the percentage of EBWL varied from 81.7 ± 21.4% to 72.2 ± 14.2%, proportional to the postoperative period; however, no statistical differences were found among the postoperative groups. Similar find ings were obtained by SEARS et al after 1 year of RYGBP in 75 patients with BMIs of 32.3 ± 8.6, and by Pajecki et al., who followed RYGBP patients for five to nine years and observed PEP% 2 years after surgery of 80.2% (BMI 29.3 ± 6.8) that decreased to 71.81% (BMI 35.5 ± 10) 5 years after surgery (18, 22) . Our findings showed a decrease in the proportion of a tendency for diabetes resolution over the long term. We think that partial weight return was seen in some individuals, al though not enough to change the anthropometric data mean of the groups; this weight gain could have precipitated the re turn of insulin resistance and the necessity for hypoglycemic drugs. However, this could also be explained by the natural progression of the disease. In fact, Pajecki et al. noted that diabetes resolution occurred in 76.5% of the patients who underwent surgery, and the cases in which only clinical im provement occurred were associated with weight gain (18, 22, 27) . The results obtained through BAROS demonstrated no differences between weight and comorbidities among groups, but after 1 and 2 years of followup, the QoL results, as measured by the MooreheadArdelt questionnaire, showed a decrease in this area among Groups 2 and 3. However, this worsening result could be a bias of the study, because it did not occur after three and 4 years or more. In fact, the main factors associated with a worsening of QoL are insufficient loss of weight and depression (21) . Hence, factors besides weight that are not being investigated, such as psychologi cal problems or not getting enough physical activity, could interfere with QoL questionnaire results.
The qualitative results from the BAROS showed that evaluation indices of very good or excellent results were greater than 90% in all groups. When we increased the num ber of the favorable results, it was observed that the rate of patients achieving good, very good, or excellent results was above 96%. Such findings are similar to those of Puzziferri et al. who obtained 86% of good, very good, or excellent results 3 years after RYGBP, and Prevedello et al. who found very good and excellent results in more than 70% of the patients, and no results that were either moderate or insufficient (19, 20) . This demonstrates that a high degree of patient satisfaction is always a positive finding.
Evaluation through use of the SF36 TM questionnaire demonstrated results of significant improvement across all domains at the first year, which coincided with sud den changes in the weight loss experience. As years went on, however, as demonstrated by Group 5, these changes persisted in the study only for the domains of functional capacity and general state of health. This result perhaps occurred because, as a result of their weight loss, patients became physically capable of working and engaging in other social activities. However, other aspects, mostly emotional ones, such as anxiety, depression, or pessimism, affected physical and mental activities by a worsening of the QoL results. In the same manner, Kinzl et al. observed a worsen ing of QoL after weight gain, mostly among women who had psychiatric or personality disorders. Laurino Neto et al. did not observed changes in SF36 domains related to physical functioning between preoperative and 3 years after RYGBP, and found a decrease in these parameters 7 years after surgery compared with preoperative perceptions (11) . On the other hand, Velcu et al. used the SF36 questionnaire to evaluate patients who underwent RYGBP 5 years post surgery, and they found no differences in the QoL in com parison to American populations who were not obese (25) . Moreover, other negative experiences can influence QoL, such as identity crises, persistent vomiting, restrictions on the ingestion of meat, and accumulation of excess skin (1, 9) . It is well known that the changes observed in the first few years after bariatric surgery related to weight loss encourage a patient's expectations of improving his or her selfesteem and facilitate his or her capacity for work and social rela tionships. The good evaluation results obtained during the initial years are justified by the effectiveness of weight loss, the favorable impact on comorbidities, and improvements in QoL. These results should be viewed by these patients as the stimulus required to change their lifestyle habits. The initial incentives prompted by the weight loss should be used in a correct manner with emphasis on physical activities, healthy nutrition, and psychological assessment to ensure longterm persistence of the favorable results obtained.
